NAC for PCOS: What the Ovulation Trials Show and How It Compares to Inositol

What Does NAC Actually Do in PCOS?

N-acetylcysteine is an amino-acid derivative, sold over the counter, best known as a precursor to glutathione, the body’s main antioxidant. The cysteine it supplies is the rate-limiting ingredient glutathione synthesis needs, which is the biochemical basis for calling NAC an antioxidant rather than a hormone or a stimulant. In PCOS research it is studied as an insulin-sensitiser and ovulation aid — the theory being that reducing oxidative stress and insulin resistance lowers the ovarian androgen output that blocks follicle development. Researchers who tested NAC in PCOS were working from earlier observations that oxidative stress markers run higher in PCOS than in women without the condition — the specific rationale that made NAC a plausible candidate rather than an arbitrary supplement someone decided to test. That is the mechanism on paper. The trials below are what actually happened when it was tested directly.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), the name a 2026 global consensus of more than 50 organisations gave the same condition. Nothing about NAC’s evidence changed with the rename; this article uses PCOS because that is still what most readers search.

What Do the Ovulation Trials Actually Show?

Four trials carry most of the evidence, and they answer three different questions: NAC added to clomiphene, NAC alone against metformin, and NAC combined with clomiphene against metformin combined with clomiphene. The populations differ too — some enrolled women who had already failed clomiphene, others had not.

Read the pattern across all four trials the same way: NAC is consistently better than nothing and consistently behind metformin. Every trial that put the two head-to-head found metformin ahead on ovulation, by a wide margin in two of them.

NAC vs Inositol for PCOS: Which One Actually Fits Your Picture?

These are different molecules with different evidence bases, and the honest answer is that inositol has the larger and more consistent trial record for ovulation in PCOS. The detail on dose, the myo- to D-chiro ratio, and what those trials found belongs on the inositol page rather than repeated here — this section is about how the two compare, not a re-explanation of inositol itself.

Nobody has run a large trial putting NAC directly against inositol in PCOS, so there is no head-to-head number to report. What exists is two separate bodies of evidence that both beat placebo but neither of which beats metformin convincingly — that is the honest state of the whole insulin-sensitising supplements category right now, not a reason to pick one over the other on marketing copy alone.

For the metformin numbers in full, including who should avoid it and what a prescriber weighs before starting it, see metformin for PCOS.

Does NAC Help Oocyte or Embryo Quality?

This is a different question from ovulation, and it has its own small evidence base. A pilot trial randomised 60 women with PCOS undergoing intracytoplasmic sperm injection (ICSI) into four groups of 15 — metformin, NAC, both combined, or placebo — for six weeks. The number of immature and abnormal oocytes fell significantly in the NAC group compared with placebo, with more good-quality embryos resulting. NAC and metformin both lowered insulin and LH compared with placebo, and NAC lowered a marker of oxidative stress (malondialdehyde) that metformin alone did not move as much.

What Dose Was Actually Used in the Trials?

There is no single agreed PCOS dose for NAC. The trials above used 1.2 g/day as an adjuvant to clomiphene, 1.8 g/day as a standalone treatment, and 1.8 g/day in the oocyte-quality pilot, typically split into two or three doses across the day. Treatment periods ran from a single clomiphene cycle to six weeks before ovulation or oocyte outcomes were measured. None of the trials followed participants for more than a few months, so there is no long-term dosing or safety data specific to PCOS to point to, and no trial has tested whether a higher or lower dose than these two changes the result.

Who NAC Will Not Help

NAC will not help you if metformin is already an option and tolerated — every head-to-head trial found metformin more effective for ovulation, sometimes by a factor of seven. It also showed no significant effect on BMI, testosterone or insulin compared with placebo in the pooled data, so if your goal is a metabolic marker rather than ovulation specifically, the trial evidence does not support expecting a change. And because no trial has isolated a PCOS phenotype that responds better, there is no evidence-based way to predict who among the responders it will work for — only that, on average, fewer people ovulate on NAC than on metformin.

It is also not a fertility treatment in its own right. Every trial above tested NAC as an addition to, or a comparison against, clomiphene or metformin — not as a standalone plan for someone who has not yet had a clomiphene-resistance conversation with a specialist. If you have not been assessed for clomiphene resistance, that assessment comes before choosing an adjuvant, not after.

Side Effects and Safety

Across the trials reviewed, NAC did not show a significant difference from placebo in adverse events, and the Salehpour 2012 trial reported no cases of ovarian hyperstimulation syndrome in the NAC group. NAC’s general safety profile outside PCOS is well established — it is the standard antidote for paracetamol overdose at much higher intravenous doses — but at oral supplement doses, mild nausea and gastrointestinal upset are the most commonly reported complaints in other populations. As with any supplement, product quality and actual per-capsule dose are not regulated the way a prescription medicine’s are, so what is on the label is not guaranteed to match what is in the capsule.

Your Next Step

If ovulation is the goal and you have not yet discussed inositol or metformin with a prescriber, that conversation should come before adding NAC — both have a stronger head-to-head record. If IVF or ICSI is on your near-term path, the oocyte-quality pilot data above is worth raising with your fertility clinic directly, since it is small enough that a clinic may want to weigh it against its own protocols rather than have you add it unprompted. If you are weighing NAC against other insulin-sensitising supplements, berberine and magnesium sit in the same category with their own trade-offs, covered on their own pages. Bring the trial numbers above to your next appointment rather than starting NAC on your own.